The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation

E-ISSN： 1873-4316|12|10|1644-1659

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.10, 2011-10, pp. : 1644-1659

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity

By Wallace M.J. Martin B.R. DeLorenzo R.J.

European Journal of Pharmacology, Vol. 452, Iss. 3, 2002-10 ,pp. : 295-301

Elsevier

Access to resources Recommend Favorite

Therapeutic Potential of Inhibiting Bruton's Tyrosine Kinase, (BTK)

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1757-1766

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoids and Peripheral Pain

By La Rana G. Lobello R.M. Piomelli D. Calignano A.

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 6, 2000-06 ,pp. : 259-262

Pharmaceutical Press

Access to resources Recommend Favorite

The Role of the Cannabinoid CB2 Receptor in Pain Transmission and Therapeutic Potential of Small Molecule CB2 Receptor Agonists

Current Medicinal Chemistry, Vol. 14, Iss. 8, 2007-04 ,pp. : 917-936

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Targeting the Endocannabinoids: Implications for the Treatment of Obesity, Metabolic Syndrome, Drug Abuse and Smoking Cessation

Current Medicinal Chemistry, Vol. 13, Iss. 22, 2006-09 ,pp. : 2669-2680

Bentham Science Publishers

Access to resources Recommend Favorite